Immix Biopharma, Inc. (IMMX) vs Sana Biotechnology, Inc. (SANA)
- Immix Biopharma, Inc. IMMX 7.98 −8.06%
- Sana Biotechnology, Inc. SANA 2.27 −8.47%
Immix Biopharma, Inc. and Sana Biotechnology, Inc. are both Biotechnology companies. Immix Biopharma, Inc. and Sana Biotechnology, Inc. are of similar size ($740.9M and $719.6M). Across the 8 metrics below, Immix Biopharma, Inc. leads on 6 and Sana Biotechnology, Inc. on 2.
Valuation
Profitability
| Metric | IMMX | SANA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (34.18%) | (152.87%) | (56.36%) |
| Return on assets | (31.34%) | (53.41%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack